Advocating the Need for a CT Coronary
Angiography Screening Program for
Prevention of Coronary Artery Disease in High – Risk
Population & guiding future pharmaceutical research
Volume 1 - Issue 2
Abhinav Aggarwal*
-
Author Information
Open or Close
- Department of Radiology, Mata Chanan Devi Hospital, India
*Corresponding author:
Abhinav Aggarwal, Junior Consultant Radiologist, Department of Radiology, Mata Chanan Devi Hospital,
Block C, Janak Puri, New Delhi, India
Received: May 25, 2018; Published: May 29, 2018
DOI: 10.32474/ACR.2018.01.000108
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Cardio-vascular disease (CVD) is one of the major causes of morbidity and mortality in Europe and world. It accounts for
majority of spend on healthcare in European Union countries and is the second on the list. Non-calcific plaques form the majority of
plaques and non-calcific & mixed plaques are responsible for majority cases of severe stenosis. Since non-calcific and mixed plaques
are resolvable by intensive statin therapy and are responsible for majority of severe acute coronary related events (vulnerable
plaques), coronary artery disease is preventable if proper screening is done which should lead to significant decrease in economic
burden of cardio-vascular & cerebro-vascular diseases. These findings warrant a discussion on systemic screening program for the
same through CT coronary angiography.
Abbrevations: CVD: Cardio-vascular disease; EU: European Union: EHN: European Heart Network; A&E: accident & emergency;
GPs: General practitioners; CTCA: Computed Tomography Coronary Angiography screening
Abstract|
Introduction|
Etiology/Disease Burden Of CVD|
Pathogenesis Of CVD|
Cost of CVD|
Taking Inspiration From Other Successfully Implemented
Screening Programs|
Role of Statins And Ideas For Further Pharmaceutical
Research|
Cost of Prospected Screening Program|
References|